Erik Wayne
Vascular Surgery · Louisville, KYNPI 1295907277
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $15,030 of the $25,032 with a category attached, or 60.0%. 28 manufacturers reported payments, led by Penumbra, Inc. at 41.3% of the total.
Across 307 payments — averaging $81.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$10K
- Boston Scientific$4K
- Abbott$2K
- W. L. Gore & Associates, Inc.$1K
- Silk Road Medical, Inc.$1K
- Cook Medical LLC$1K
- plus $4K from 22 others
What the payments were for
- Speaking & faculty fees$8,40034%
- Travel & lodging$1,5526%
- Food & beverage$15,03060%
- Education$500%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 22 | $10,340 |
| Boston Scientific | 78 | $4,034 |
| Abbott | 62 | $2,351 |
| W. L. Gore & Associates, Inc. | 16 | $1,465 |
| Silk Road Medical, Inc. | 22 | $1,434 |
| Cook Medical LLC | 30 | $1,370 |
| Bolton Medical Inc | 8 | $1,193 |
| EKOS Corporation | 9 | $837 |
| Endologix LLC | 5 | $493 |
| Cardiovascular Systems Inc. | 15 | $353 |
| Stryker | 4 | $198 |
| Smith+Nephew | 1 | $171 |
| Sanara Medtech Inc. | 1 | $168 |
| Terumo Medical Corporation | 5 | $103 |
| Bard Peripheral Vascular, Inc. | 6 | $100 |
| E.r. Squibb & Sons, L.L.C. | 6 | $88 |
| Medtronic | 3 | $53 |
| AbbVie | 1 | $51 |
| Cerus Corporation | 2 | $40 |
| Inari Medical, Inc. | 2 | $39 |
| Baxter Healthcare | 2 | $35 |
| Getinge USA Sales, LLC | 1 | $30 |
| Atricure, Inc. | 1 | $26 |
| Philips North America LLC | 1 | $16 |
| Dilon Technologies, Inc. | 1 | $15 |
| Elutia, Inc. | 1 | $12 |
| Pfizer | 1 | $11 |
| Kerecis Limited | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$6,231
- Indigo$2,400
- RUBY Coil$1,200
- ENROUTE Transcarotid Neuroprotection System$1,102
- EKOSONIC$828
- GENERAL VASCULAR INTERVENTION$710
- ENROUTE Transcarotid Stent System$600
- ENHANCE Transcarotid Peripheral Access Kit$600
- ENROUTE 0.014 Guidewire$600
- ENROUTE Transcarotid Stent$502
- ESPRIT$482
- GORE TAG Conformable Thoracic Endoprosthesis$377
- Ovation$312
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$292
- TREO ABDOMINAL STENT-GRAFT SYSTEM$272
- JETi Peripheral Catheter$257
- Zilver PTX$249
- GORE VIABAHN VBX Balloon Expandable Endo$242
- Zenith$240
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$222
How this compares
$25,032 in reported general payments places this provider in the 85th percentile of 72 vascular surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $13,767 |
| ClopidogrelClopidogrel Bisulfate | 73 | $330 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $11 | $13,76722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 72 vascular surgery providers in Kentucky.
Other vascular surgery in Louisville
- Amit DwivediLouisville$406K
- Abindra SigdelLouisville$84K
- Ferenc NagyLouisville$47K
- Gregory SchmiederLouisville$44K
- Matthew JungLouisville$24K
- Nancy ClarkLouisville$19K
- Ashlee VinyardLouisville$12K
- Salem GeorgeLouisville$10K
- Nathaniel LiuLouisville$10K
- Hazaim AlwairLouisville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.